주 메뉴 바로가기 본문으로 바로가기

전체 메뉴 사이트맵

닫기

본문 바로가기

정책동향

홈 > BT동향 > 정책동향

scrap print facebook twitter naverBand url
글 읽기

National Biotechnology Development Strategy 2014 : India

분류 정책동향 > 종합
출처 Department of Biotechnology Ministry of Science & Technology Government of India 조회 2793
자료발간일 2014-02-24 등록일 2014-04-08
첨부파일

바이오기술개발전략 - India.pdf(1205.441 KB)

내용바로가기 http://www.dbtindia.nic.in/?s=National+Biotechnology+Development+Strategy+2014+%3A+India
평점 평점이 없습니다.
 
SECTION . I EXECUTIVE SUMMARY
 
In Fulfilment of Biotechnology Vision 2020
 
Moving Ahead From Strategy- I of 2007
 
The Department of Biotechnology (DBT), Government of India, announced the National Biotechnology Development Strategy in September 2007. Through the strategy, biotechnology was recognized as a sunrise sector that needed sed attention. The cornerstone of the strategy was to on building coherence and connectivity between disciplines and bring together variegated skills across sectors to enhance synergy. The strategy sought to address a number of challenges in terms of R&D; creation of investment capital; technology transfer, absorption and diffusion; intellectual property regime; regulation standards and accreditation; tailor-made human capital for science and innovation and public understanding of biotechnology.
Most of the new initiatives announced in the 2007 Strategy are in place as can be seen in the Annexure.

Further, new and novel institutional mechanisms inspired by the government, but functioning outside it, have been put in place to facilitate a march towards genuine world-class technological competence, biotech innovation and increased national impact. While recognizing several accomplishments, it should be pointed out that one of the major challenges, still requiring attention, is the issue of biotechnology regulation.
 
Meanwhile, boundaries between disciplines once considered distant are now beginning to and as a consequence of their convergence given birth to newer opportunities and challenges. In light of this, it is important to redefine the paradigm of relationship between government, academia, industry and civil society. This is critical for the new era of science-driven, society relevant innovation and entrepreneurship. Newer instruments of connectivity are continuously needed. Scale up and sustainability are important for novel efforts and approaches to make institutional mechanisms of innovation empowering. Human resource policies have to be reshaped to bring in breadth and depth as accelerated growth is propelled by both a highly skilled work force and talented leadership. Our universities need to be redesigned for evolving an ecosystem in which scientists, innovators and future entrepreneurs can be nurtured. University research output must show a quantum jump for us to achieve global competitiveness. Regulation, standard setting and support of infrastructure for all this require attention on priority.
  
 
....(계속)
 
 
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
 
 
관련기사
국외뉴스 India’s DNA COVID vaccine is a world first ? more are coming 2021-09-06
국외뉴스 A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India 2021-07-26
국외뉴스 India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says 2021-07-05
국외뉴스 COVID-19 and SOS tweets in India 2021-06-23
국외뉴스 What to know about the delta COVID-19 variant first detected in India 2021-06-14
국외뉴스 India’s COVID crisis flags need to forecast variants 2021-06-02
국외뉴스 Vietnam says it has detected a more contagious hybrid of variants first seen in India and Britain. 2021-05-31
국외뉴스 Everything you need to know about B.1.617.2, the “Indian variant” of coronavirus 2021-05-18
국외뉴스 India variant could lead to serious third wave of Covid in UK 2021-05-17
국외뉴스 EU agency says mRNA jabs 'promising' against India variant 2021-05-14